Hansen Gwenn Insider Trades & Stock Holdings

Chief Scientific Officer · Nurix Therapeutics, Inc. · Latest filing Oct 15, 2026

Hansen Gwenn, Chief Scientific Officer at Nurix Therapeutics, Inc. has 1 Form 4 trade on file since Oct 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($36.30K), net -$36.30K. Latest filing: disposed of 1.45K shares of $NRIX on Oct 15, 2026 at $25.

Trades on file

1

Open-market bought

$0

Open-market sold

$36.30K

Net open-market

-$36.30K

Latest filing

Oct 15, 2026

All insider trades by Hansen Gwenn

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 15, 2026	$NRIX	Sell (Open-market sale) 10b5-1	1.45K	$25	$36.30K						Chief Scientific Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Hansen Gwenn traded

• $NRIX

Frequently asked questions

Has Hansen Gwenn been buying or selling stock?

Hansen Gwenn has 0 open-market purchases and 1 open-market sale on file, net -$36.30K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Hansen Gwenn's latest insider trade?

disposed of 1.45K shares of $NRIX on Oct 15, 2026 at $25.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.